Text Mining for the Vaccine Adverse Event Reporting System: Medical Text Classification Using Informative Feature Selection
Overview
Affiliations
Objective: The US Vaccine Adverse Event Reporting System (VAERS) collects spontaneous reports of adverse events following vaccination. Medical officers review the reports and often apply standardized case definitions, such as those developed by the Brighton Collaboration. Our objective was to demonstrate a multi-level text mining approach for automated text classification of VAERS reports that could potentially reduce human workload.
Design: We selected 6034 VAERS reports for H1N1 vaccine that were classified by medical officers as potentially positive (N(pos)=237) or negative for anaphylaxis. We created a categorized corpus of text files that included the class label and the symptom text field of each report. A validation set of 1100 labeled text files was also used. Text mining techniques were applied to extract three feature sets for important keywords, low- and high-level patterns. A rule-based classifier processed the high-level feature representation, while several machine learning classifiers were trained for the remaining two feature representations.
Measurements: Classifiers' performance was evaluated by macro-averaging recall, precision, and F-measure, and Friedman's test; misclassification error rate analysis was also performed.
Results: Rule-based classifier, boosted trees, and weighted support vector machines performed well in terms of macro-recall, however at the expense of a higher mean misclassification error rate. The rule-based classifier performed very well in terms of average sensitivity and specificity (79.05% and 94.80%, respectively).
Conclusion: Our validated results showed the possibility of developing effective medical text classifiers for VAERS reports by combining text mining with informative feature selection; this strategy has the potential to reduce reviewer workload considerably.
The Impact of Artificial Intelligence on Allergy Diagnosis and Treatment.
Khan M, Banerjee S, Muskawad S, Maity R, Chowdhury S, Ejaz R Curr Allergy Asthma Rep. 2024; 24(7):361-372.
PMID: 38954325 DOI: 10.1007/s11882-024-01152-y.
Ball R, Talal A, Dang O, Munoz M, Markatou M J Med Internet Res. 2024; 26:e50274.
PMID: 38842929 PMC: 11190620. DOI: 10.2196/50274.
Somayajula S, Litake O, Liang Y, Hosseini R, Nemati S, Wilson D Sci Rep. 2024; 14(1):85.
PMID: 38168099 PMC: 10761882. DOI: 10.1038/s41598-023-48594-4.
Zitu M, Zhang S, Owen D, Chiang C, Li L Front Pharmacol. 2023; 14:1218679.
PMID: 37502211 PMC: 10368879. DOI: 10.3389/fphar.2023.1218679.
Kim S, Kang T, Chung T, Choi Y, Hong Y, Jung K Drug Saf. 2023; 46(8):781-795.
PMID: 37330415 PMC: 10344995. DOI: 10.1007/s40264-023-01323-2.